Key facts
- Cerillo’s last known valuation is $8.4M (Nov 2023).
- It has raised $5.3M across 4 recorded rounds; the latest was Seed Round ($1.1M) in Feb 2025.
- Notable investors include US National Science Foundation, MedTech Innovator, Virginia Innovation Partnership Corporation, Virginia Venture Partners, BioTools Innovator — 12 tracked in total.
- Cerillo has filed 5 Form Ds with the SEC since 2021, most recently Mar 2025 ($1.1M sold to 11 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Cerillo
Funding rounds
4 roundsAbout Cerillo
Developer of biological laboratory instruments designed to make common biological research tasks simple. The company's instruments include a multiwell plate reader whose unprecedentedly small size allows it to work in small labs, enabling researchers to expand their abilities to characterize microbes exponentially.
- Sector
- Healthcare
- HQ
- Charlottesville, VA, United States
- Founded
- 2016
- Employees
- 20
- Website
- cerillo.bio/
- Ownership
- Privately Held (backing)
Cerillo doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cerillo shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cerillo in its N-PORT filings yet. We sweep new filings monthly.